The reference lab noted unusual melt temperatures in samples processed for Lyme disease, and collaborated with others to find the spirochete in Upper Midwest ticks.
The Swedish firm, a spinout of Lund University, will evaluate the array-based blood tests to confirm, rule out, and monitor the autoimmune disease.
The company aims to enroll 3,000 women in the registry, which it plans to use for research and development of tests to detect and manage pelvic masses.
The company also halved its net losses for the quarter compared to last year, but still fell short of analyst expectations.
They will work to accelerate the launch of Celmatix's infertility genetics tests and develop early screening tests for declining ovarian function.
In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.
President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.
Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.
Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.